AK-R215 Pharmacokinetic Study Phase I

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
An open label, randomized, 2-sequence, 2-period, single-dose cross-over study to evaluate the pharmacokinetics characteristics of AK-R215
Epistemonikos ID: c6a9cbdc08958ff14917b25dade8cdd88d6da1fb
First added on: May 21, 2024